ESC Professional Premium Access

The prognostic interplay of heart failure and chronic kidney disease in atrial fibrillation, focus on cardiorenal outcomes

Congress Presentation

About the speaker

Doctor Ulrike Baumer

Vienna (Austria)
0 follower

7 more presentations in this session

Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials

Speaker: Doctor G. Costa (Coimbra, PT)

Thumbnail

Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach

Speaker: Miss N. Atzemian (Zurich, CH)

Thumbnail

Inflammation and long-term outcomes after first-time direct current cardioversion for atrial fibrillation: a nationwide register study

Speaker: Doctor A. Langhoff (Copenhagen, DK)

Thumbnail

Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries

Speaker: Doctor J. Imberti (Modena, IT)

Thumbnail

Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?

Speaker: Doctor L. Echeverria (Floridablanca, CO)

Thumbnail

Access the full session

Management of comorbidities and outcomes in atrial fibrillation (1)

Speakers: Doctor U. Baumer, Doctor G. Costa, Miss N. Atzemian, Doctor A. Langhoff, Doctor J. Imberti...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations